Story: Marine Biomedical Story 1
Episode: 2
Presenter: Christina Morrissey
Air Date: 14th April 2024

Pioneering Sustainable Solutions in Biotech Using Pearl shell Innovations.

• Innovative patenting technology allows for the transformation of pearl shell into human bone materials, marking a breakthrough in orthopaedic treatments.
• PealBoneTM, derived from MSC certified WA pearl oyster shells, is tailored to address fractures caused by osteoporosis or trauma, potentially revolutionizing natural bone substitutes globally.
• The direct sourcing of pearl shells from Broome, facilitated by local commercial companies, ensures a unique chemical structure and non-toxic profile, enhancing the safety of the implants for human use.
• Establishment of a manufacturing facility and adherence to Good Manufacturing Practices (GMP) in Broome mark a significant milestone, being the first of its kind in northern Australia, underscoring the region's potential as a hub for biotech innovation.
• Marine Biomedical's commitment to sustainability is evident through the utilization of marine-derived by-products from certified commercial fisheries, furthering environmental stewardship in the medical industry.

For more information, head to:
https://marinebiomedical.com.au/